FILSPARI is the only Dual Endothelin Angiotensin Receptor Antagonist ... 50% of maximum label dose and maximally tolerated angiotensin-converting enzyme (ACE) inhibitors or ARB therapy.

In accordance with Table 1, among all the countries ... 3 blood pressure, #4 receptor blocker, #5 vascular risk factor, #6 current evidence, #7 public health, #8 targeting renin-angiotensin system, #9 ...

Further optimization of the receptor blocker Researchers have since further optimized the substance, making it even more effective while also increasing its duration of effect for suitability as a ...

The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response. The study findings have been published in the journal Signal Transduction and Targeted Therapy.

The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response. The study findings have been published in the journal Signal Transduction and Targeted Therapy.